Servier to Acquire Day One Biopharmaceuticals in Multibillion-Dollar Deal to Bolster Rare Oncology Portfolio
admin French pharmaceutical giant Servier has reached a definitive agreement to acquire Day One Biopharmaceuticals, a...
Biotech, Pharma & Cancer Drug Development
Controversial FDA Vaccines and Gene Therapies Chief Vinay Prasad Resigns Amid Tumultuous Tenure and Regulatory Disputes
Vinay Prasad, the polarizing figure who has led the Food and Drug Administration’s critical office...
Alnylam Forges Landmark $1.23 Billion Cardiovascular Discovery Alliance with Tenaya Therapeutics to Advance Disease-Modifying Therapies
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo
The pharmaceutical landscape for multiple myeloma has witnessed a significant acceleration with the U.S. Food...